Bausch and Lomb Retina Revenue and Competitors

Kirkwood, MO USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Bausch and Lomb Retina's estimated annual revenue is currently $35.1M per year.(i)
  • Bausch and Lomb Retina's estimated revenue per employee is $251,000

Employee Data

  • Bausch and Lomb Retina has 140 Employees.(i)
  • Bausch and Lomb Retina grew their employee count by -5% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$25.6M1020%N/AN/A
#2
$35.9M143-1%N/AN/A
#3
$7.8M317%N/AN/A
#4
$2.3M980%N/AN/A
#5
$75M231N/AN/AN/A
#6
$13.8M55-8%N/AN/A
#7
$35M1900%$80MN/A
#8
$11.5M46-8%N/AN/A
#9
$35.1M140-5%N/AN/A
#10
$9.5M38-3%N/AN/A
Add Company

As Synergetics becomes Bausch + Lomb Retina, keep following us to learn why our newly formed partnership is all about you. We are excited to show you how, united, we can help you achieve more than ever. We will not be content to work within current technologies, but rather we will create new possibilities to expand the horizons of the entire field of retinal surgery. It is our priority to continue providing you with new possibilities in ophthalmology. Our integrated research and development team has the resources and the talent to help you achieve more. By preparing for what will to come, rather than reacting to what has already happened, we will ensure that you can perform at your highest level. We can meet all of your needs, from disposable instrumentation to a complete vitrectomy system, with our outstanding product lines and complete portfolio. We're better together, and this is just the beginning of what's to come.

keywords:N/A

N/A

Total Funding

140

Number of Employees

$35.1M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Bausch and Lomb Retina News

2022-03-22 - Vitreoretinal Surgery Devices Market to Witness Dynamic Growth at ...

In July 2019 Bausch + Lomb announced the launch of the FreeFlow infusion system for retina surgery and the 23-gauge Bi-Blade dual-port...

2022-03-22 - Xipere launches in US - Ophthalmology

... to a press release from Bausch + Lomb and Clearside Biomedical. ... agents to the retina and choroid, according to the release.

2022-03-22 - Bausch + Lomb and Clearside Biomedical Announce the US ...

Macular edema is the buildup of fluid in the macula, which causes retinal swelling and distorted vision, and if left untreated, may lead to...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M1570%N/A
#2
$15M261N/AN/A
#3
$121.2M35910%N/A
#4
$200.1M59311%N/A
#5
$35M599-1%N/A